Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara E Dugan

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
The Mental Health Clinician|December 8, 2025
Safety considerations for patients using cannabisSara E Dugan
Psychiatric Services (Washington, D.C.)|June 25, 2020
Informed Consent: A Policy Prescription for Communicating Benefit and Risk in State Medical Marijuana ProgramsErik Messamore, Sara E Dugan
Clinical Therapeutics|April 28, 2009
Varenicline: a first-line treatment option for smoking cessationGina Daubney Garrison, Sara E Dugan
The Annals of Pharmacotherapy|November 4, 2004
Duloxetine: a dual reuptake inhibitorSara E Dugan, Matthew A Fuller
American Journal of Pharmaceutical Education|March 23, 2022
Feeding the Soul via Creation of a Suborganization to Promote a Sense of CommunityCaitlin M Gibson, Suzanne Larson, Erin M Behnen, et al.
Community Mental Health Journal|November 28, 2015
Disease Burden Among Individuals with Severe Mental Illness in a Community SettingKristin R Baughman, Natalie Bonfine, Sara E Dugan, et al.
The Journal of Clinical Psychiatry|May 24, 2019
Prevalence and Predictors of Benzodiazepine Monotherapy in Patients With Depression: A National Cross-Sectional StudyMate M Soric, Chris Paxos, Sara E Dugan, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
The Mental Health Clinician|December 8, 2025
Safety considerations for patients using cannabisSara E Dugan
Psychiatric Services (Washington, D.C.)|June 25, 2020
Informed Consent: A Policy Prescription for Communicating Benefit and Risk in State Medical Marijuana ProgramsErik Messamore, Sara E Dugan
Clinical Therapeutics|April 28, 2009
Varenicline: a first-line treatment option for smoking cessationGina Daubney Garrison, Sara E Dugan
The Annals of Pharmacotherapy|November 4, 2004
Duloxetine: a dual reuptake inhibitorSara E Dugan, Matthew A Fuller
American Journal of Pharmaceutical Education|March 23, 2022
Feeding the Soul via Creation of a Suborganization to Promote a Sense of CommunityCaitlin M Gibson, Suzanne Larson, Erin M Behnen, et al.
Community Mental Health Journal|November 28, 2015
Disease Burden Among Individuals with Severe Mental Illness in a Community SettingKristin R Baughman, Natalie Bonfine, Sara E Dugan, et al.
The Journal of Clinical Psychiatry|May 24, 2019
Prevalence and Predictors of Benzodiazepine Monotherapy in Patients With Depression: A National Cross-Sectional StudyMate M Soric, Chris Paxos, Sara E Dugan, et al.
Pageof 1